Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Clinical trial NCT07221513 · WITHDRAWN

Trial details

NCT number: NCT07221513
Sponsor: Salubris Biotherapeutics Inc
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

HFrEF - Heart Failure With Reduced Ejection Fraction HFpEF - Heart Failure With Preserved Ejection Fraction Group 2 Pulmonary Hypertension

Start date: 2025-12-15
Primary completion: 2026-04-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.